TY - JOUR
T1 - Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction
T2 - The View of the Preventive Cardiologist
AU - Shah, Nishant P.
AU - Cainzos-Achirica, Miguel
AU - Feldman, David I.
AU - Blumenthal, Roger S.
AU - Nasir, Khurram
AU - Miner, Martin M.
AU - Billups, Kevin L.
AU - Blaha, Michael J.
N1 - Funding Information:
Funding: MC-A was supported by a research grant from the Spanish Society of Cardiology .
Publisher Copyright:
© 2016 Elsevier Inc. All rights reserved.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Vascular erectile dysfunction is a powerful marker of increased cardiovascular risk. However, current guidelines lack specific recommendations on the role that the evaluation of vascular erectile dysfunction should play in cardiovascular risk assessment, as well on the risk stratification strategy that men with vascular erectile dysfunction should undergo. In the last 3 years, erectile dysfunction experts have made a call for more specific guidance and have proposed the selective use of several prognostic tests for further cardiovascular risk assessment in these patients. Among them, stress testing has been prioritized, whereas other tests are considered second-line tools. In this review, we provide additional perspective from the viewpoint of the preventive cardiologist. We discuss the limitations of current risk scores and the potential interplay between erectile dysfunction assessment and the use of personalized prognostic tools, such as the coronary artery calcium score, in the cardiovascular risk stratification and management of men with vascular erectile dysfunction. Finally, we present an algorithm for primary care physicians, urologists, and cardiologists to aid clinical decision-making.
AB - Vascular erectile dysfunction is a powerful marker of increased cardiovascular risk. However, current guidelines lack specific recommendations on the role that the evaluation of vascular erectile dysfunction should play in cardiovascular risk assessment, as well on the risk stratification strategy that men with vascular erectile dysfunction should undergo. In the last 3 years, erectile dysfunction experts have made a call for more specific guidance and have proposed the selective use of several prognostic tests for further cardiovascular risk assessment in these patients. Among them, stress testing has been prioritized, whereas other tests are considered second-line tools. In this review, we provide additional perspective from the viewpoint of the preventive cardiologist. We discuss the limitations of current risk scores and the potential interplay between erectile dysfunction assessment and the use of personalized prognostic tools, such as the coronary artery calcium score, in the cardiovascular risk stratification and management of men with vascular erectile dysfunction. Finally, we present an algorithm for primary care physicians, urologists, and cardiologists to aid clinical decision-making.
KW - Atherosclerosis
KW - Cardiovascular disease
KW - Coronary artery calcium
KW - Erectile dysfunction
KW - Prevention
KW - Risk
KW - Vascular erectile dysfunction
UR - http://www.scopus.com/inward/record.url?scp=84958054157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958054157&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2015.08.038
DO - 10.1016/j.amjmed.2015.08.038
M3 - Review article
C2 - 26477950
AN - SCOPUS:84958054157
SN - 0002-9343
VL - 129
SP - 251
EP - 259
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 3
ER -